CEP-37440

DB13060InvestigationalSmall molecule

CEP-37440 has been used in trials studying the treatment of Solid Tumors.

Mechanism: Pharmacologically active on ALK tyrosine kinase receptor and Focal adhesion kinase 1
Curator reviewed
Formula / weight: C₃₀H₃₈ClN₇O₃ · 580.13 g/mol (avg)
Code names: CEP-37440

Resolves to

Compound

Structure

InChIKeyBCSHRERPHLTPEE-NRFANRHFSA-NSMILESCNC(=O)C1=CC=CC=C1NC1=C(Cl)C=NC(NC2=CC=C3C[C@H](CCCC3=C2OC)N2CCN(CCO)CC2)=N1

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with CEP-37440, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.